![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, February 25, 2017 9:26:34 PM
Actions tend to speak louder than words. Trump's appointed members signal that they will be resistant towards recreational MJ. He's keeping Chuck Rosenberg as head of DEA. He just got Sessions appointed as AG. We all know their stances on MJ.
MJ proponents will have to hope that Epidiolex gains FDA approval, b/c that torpedoes the whole schedule 1 listing for MJ. That approval may be a double-edged sword for CBD distribution companies though.
The recent proposed bill in Congress still faces many political hurdles.
I'm expecting plenty of legal battles between states and the Fed over this subject in the coming months/years.
My posts are solely my opinion unless presented with (or directed to) factual information. All investors are strongly encouraged by myself to do their own due diligence before making an investment decision.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM